Compounds > 1,1,2,2-tetramethyl-1,2-bis(4'-hydroxyphenyl)ethane
Page last updated: 2024-09-03

1,1,2,2-tetramethyl-1,2-bis(4'-hydroxyphenyl)ethane and Bone Diseases, Metabolic

1,1,2,2-tetramethyl-1,2-bis(4'-hydroxyphenyl)ethane has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauss, F; Feldmann, S; Lempert, UG; Minne, HW; Parvizi, S; Pfeifer, M; Ziegler, R1

Other Studies

1 other study(ies) available for 1,1,2,2-tetramethyl-1,2-bis(4'-hydroxyphenyl)ethane and Bone Diseases, Metabolic

ArticleYear
Antiestrogen and antiandrogen administration reduce bone mass in the rat.
    Bone and mineral, 1989, Volume: 7, Issue:3

    Topics: Androgen Antagonists; Animals; Bone Density; Bone Diseases, Metabolic; Cyproterone; Cyproterone Acetate; Estrogen Antagonists; Female; Hexestrol; Male; Orchiectomy; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Tamoxifen; Testosterone

1989